Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.490
+0.040 (2.76%)
Apr 29, 2025, 12:48 PM EDT - Market open
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $33.22 million as of April 29, 2025. Its market cap has decreased by -87.15% in one year.
Market Cap
33.22M
Enterprise Value
-72.60M
1-Year Change
-87.15%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $33.22M, a decrease of -90.66%. That is a compound annual growth rate of -88.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 32.33M | -50.00% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.80B |
| UnitedHealth Group | 382.29B |
| Johnson & Johnson | 373.78B |
| AbbVie | 340.25B |
| Novo Nordisk | 280.41B |
| Abbott Laboratories | 224.65B |
| AstraZeneca | 218.53B |
| Novartis AG | 214.73B |